Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Comparison of Dopamine D2 Receptor (Homology Model and X-ray Structure) and Virtual Screening Protocol Validation for the Antagonism Mechanism

Emanuel Dani Ramdani, Arry Yanuar, Raymond Rubianto Tjandrawinata.




Abstract
Cited by 1 Articles

The present research work aims to compare the homology model and recent X-ray crystal structure of Dopamine D2 receptor [PDB Code: 6CM4] as well as to validate the virtual screening protocol for antagonist compounds. The comparison involved the sequence and similarity and the capability of both proteins to produce similar risperidone binding pose with co-crystal structure based on ChemPLP score and Tanimoto Coefficient score generated by PLANTS and Pyplif. Homology model failed to give the correct binding pose as the RMSD fell to >2 Å even with similar sequence and folding. Therefore, 6CM4 should be used for virtual screening instead the homology model. The virtual screening protocol validation of 6CM4 was performed by using PLANTS followed by Pylif filtering. The protocol was able to give EF1% value of 6.238, which was better than the EF1% value of protein Dopamin D3 receptor that shared >80% similarity with Dopamin D2 receptor. Similarity between the docking pose and the actual pose is considered important to obtain better predictivity.

Key words: Dopamine D2, 6CM4, Homology Model, PLANTS, Pylif






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.